Suchergebnisse - "Weinstock, Chana"

PubPharm (32)

1

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer : A US Food and Drug Administration Pooled Analysis

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Fallah, J. | Xu, J. | Weinstock, C. | +10

2

Cytoreductive nephrectomy in the era of immune checkpoint inhibitors : a U.S. FDA pooled analysis

enthalten in: Journal of the National Cancer Institute | 2024

von Fallah, J. | Gittleman, H. | Weinstock, C. | +7

3

FDA Approval Summary : Enfortumab Vedotin Plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Maguire, W. | Lee, D. | Weinstock, C. | +11

4

A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Chang, E. | Zhou, J. | Song, C. | +15

5

FDA Approval Summary : Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Fallah, J. | Xu, J. | Weinstock, C. | +20

6

A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma

enthalten in: European urology | 2023

von Lee, D. | Gittleman, H. | Weinstock, C. | +12

CommentIn: Eur Urol. 2023 Oct;84(4):379-380. - PMID 37455176

7

FDA Approval Summary : Belzutifan for VHL Disease Tumors-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Fallah, J. | Weinstock, C. | Mehta, G. | +6

CommentOn: Clin Cancer Res. 2022 Nov 14;28(22):4843-4848. - PMID 35727604

8

FDA Approval Summary : Belzutifan for von Hippel-Lindau Disease-Associated Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Fallah, J. | Brave, M. | Weinstock, C. | +19

CommentIn: Clin Cancer Res. 2023 Feb 1;29(3):685. - PMID 36722139

9

Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer

enthalten in: European urology | 2022

von Weinstock, C. | Agrawal, S. | Chang, E.

CommentOn: Eur Urol. 2022 Jul;82(1):34-46. - PMID 34955291

10

Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score-Reply

enthalten in: JAMA oncology | 2022

von Weinstock, C. | Amatya, A. | Beaver, J.

CommentOn: JAMA Oncol. 2022 Feb 1;8(2):232-240. - PMID 34989781